ROSA Oligomineral Water for Oral Hydration in 6-Month-Old Healthy Infants (ROSAH)

Short-term Safety of ROSA Oligomineral Water in Healthy Serbian Infants

The present study evaluates the safety of ROSA oligomineral water in 6-to-12-month old healthy children.

Study Overview

Status

Completed

Conditions

Detailed Description

Our study is designed as an open-label case-control interventional study that evaluates the safety of 28-day hydration with ROSA water in healthy infants aged 6-12 months. The participants are apparently healthy children breastfed or formula fed; minimal sample size (n = 52) was calculated according to 0.8 power to detect a significant difference in the prevalence of diarrhea (G*Power 3.1). Final group of participants will consist of sixty-five healthy male and female infants (we presume that 20% of participants will drop-out throughout the study). The stopping rules for participants include a refuse to participate in this research at any time and significant change of health status. All participants will be allocated in an open-label manner to two randomly assigned ad libitum hydration regimens: first group will receive ROSA water for daily hydration, and second (control) group will receive other water of personal choice (including tap water). All testing including parental diary of infant general status (e.g. daily amount of water consumed, number of stools per day, nutritional habits) and clinician-reported outcomes (e.g. body weight, clinical evaluation of hydration will be conducted at pre-administration (baseline) and at follow-up (after 28 days of administration). The study is entirely voluntary and the participants are free to stop participating at any time.

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Niš, Serbia
        • Dom zdravlja Nis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 1 year (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 6 to 12 months
  • Healthy children
  • Doubled weight at 6 months
  • Tripled weight at 12 months
  • Feed with breast milk of milk formula

Exclusion Criteria:

  • Any acute or chronic disease
  • Unwillingness to return for follow-up analysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: ROSA water
Ad libitum hydration with ROSA oligomineral water
Ad libitum hydration with ROSA oligomineral water
ACTIVE_COMPARATOR: Control water
Ad libitum hydration with other waters
Ad libitum hydration with other waters

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Daily amount of water consumed
Time Frame: Baseline vs. 28-days
Monitor change in daily amount of water consumed
Baseline vs. 28-days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of stools per day
Time Frame: Baseline vs. 28-days
Monitor change in number of stools per day
Baseline vs. 28-days
Body weight
Time Frame: Baseline vs. 28-days
Monitor change in body weight
Baseline vs. 28-days
Hydration status
Time Frame: Baseline vs. 28-days
Monitor clinican-reported change in hydration status
Baseline vs. 28-days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Milorad Jerkan, MD, PhD, Dom zdravlja Nis

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 20, 2019

Primary Completion (ACTUAL)

August 31, 2019

Study Completion (ACTUAL)

October 7, 2019

Study Registration Dates

First Submitted

July 4, 2019

First Submitted That Met QC Criteria

July 4, 2019

First Posted (ACTUAL)

July 9, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 16, 2019

Last Update Submitted That Met QC Criteria

October 15, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 01-CC2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hydration

Clinical Trials on ROSA Water

3
Subscribe